Detoxification From the Lipid Tract
Conditions: COVID-19 Vaccine Adverse Reaction Interventions: Device: electroencephalogram biofeedback; Device: electrical brain stimulation; Device: ultra-low frequency transcranial magnetic stimulation; Drug: Sertraline Hydrochloride; Drug: Clonazepam; Drug: Alprazolam; Drug: Metoprolol; Drug: Olanzapine; Drug: Pravastatin Sodium 20 MG; Drug: Sacubitril Valsartan Sodium Hydrate Sponsors: Pachankis, Yang I., M.D.; First Affiliated Hospital of Chongqing Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions
Conditions: Bioequivalence Study Interventions: Drug: Sacubitril and Valsartan Tablets 49mg/51mg; Drug: Entresto ® (Sacubitril and Valsartan Tablets 49mg/51mg) Sponsors: Viatris Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions
Conditions: Chronic Heart Failure Interventions: Drug: Sacubitril and Valsartan Tablets 97mg/103mg; Drug: Entresto (Sacubitril and Valsartan Tablets 97mg/103mg) Sponsors: Viatris Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
Sacubitril 97 mg and Valsartan 103 mg Film-coated Tablets Relative to Entresto 97 mg/103 mg Film-coated Tablets
Conditions: Healthy Subjects Interventions: Drug: Sacubitril and Valsartan-Test product; Drug: Sacubitril and Valsartan-Reference product Sponsors: Bio-innova Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
Conditions: Heart Failure, Congestive Interventions: Drug: Furosemide; Drug: Torsemide; Drug: Bumetanide; Drug: sacubitril/valsartan; Drug: Hydralazine; Drug: Isosorbide Dinitrate Sponsors: Heart Center Research, LLC; Boston Scientific Corporation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions
Conditions: Healthy Volunteers Interventions: Drug: Sacubitril and Valsartan Sodium Tablets 24 mg/26 mg; Drug: Entresto 50 mg Sponsors: Dr. Reddy ' s Laboratories (Thailand) Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
Bioequivalence Study of Amlodipine/Valsartan 10/160 Film Coated Tablets
Conditions: Healthy Volunteer Interventions: Drug: Amlodipine/Valsartan; Drug: Amlodipine 10 mg&valsartan 160 mg (Exforge) Sponsors: International Bio service Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
Bioequivalence Study of Amlodipine/Valsartan 10/160 mg Film Coated Tablets
Conditions: Healthy Volunteer Interventions: Drug: Amlodipine/Valsartan; Drug: Amlodipine 10 mg&valsartan 160 mg (Exforge) Sponsors: International Bio service Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
National Registry of Adult Heart Failure Patients With Complex Congenital Heart Disease: Systemic Right Ventricle and Single Ventricle Treated With Sacubitril/Valsartan
Conditions: Complex Congenital Heart Disease Interventions: Drug: Sacubitril / Valsartan Oral Tablet [Entresto] Sponsors: University Hospital, Grenoble Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials
A Safety Study of Sacubitril/Valsartan in Japanese Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed CLCZ696B2319E1 Study
Conditions: Heart Failure Interventions: Drug: sacubitril/valsartan Sponsors: Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure
Conditions: Heart Failure Interventions: Biological: Placebo; Biological: XXB750 Low dose; Biological: XXB750 Medium Dose; Biological: XXB750 High Dose; Drug: Sacubitril/valsartan Sponsors: Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
Is Sacubitril-valsartan Superior to Dapagliflozin in Improving Myocardial Function Performance
Conditions: Heart Failure Interventions: Diagnostic Test: myocardial function after surgery Sponsors: Ain Shams University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials
Repurposing Valsartan May Protect Against Pulmonary Hypertension
Conditions: Pulmonary Arterial Hypertension; Right Heart Failure; Right Ventricular Dysfunction; Pulmonary Vascular Disorder Interventions: Drug: Valsartan 40 mg; Drug: Placebo Sponsors: University of Washington; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
